Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Sub: Reconciliation Of Share Capital Audit For The Quarter Ended 30.06.2022 As Per Regulation 76 Of The SEBI (DP) Regulation,2018

 We are enclosing herewith the Reconciliation of Share Capital Audit Report for the quarter ended 30th June 2022 as per Regulation 76 of the SEBI (Depositories and Participants) Regulation 2018 and in terms of Circular No. CIR/MRD/DP/30/2010 dated 06.09.2010 issued by SEBI. Request you to take the same on record.
09-07-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Closure of Trading Window

 This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of conduct for Prevention of Insider Trading Regulations, the trading window for dealing in the Company shares shall remain closed from Friday, July 1, 2022 till the end of 48 hours after declaration of financial results for the quarter and year ending on 30th June 2022 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company
30-06-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are submitting herewith the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2022 duly issued by M/s. Eswaramoorthy and company Practicing Company Secretaries, Coimbatore
30-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of Newspaper Advertisement published on May 26th and May 27th, 2022 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on May 25,2022.
27-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Appointment Of Chief Financial Officer

 With reference to the captioned subject matter and pursuant to Regulation 30 (6) of the Listing Regulations read with Para A of Part A of Schedule III of the said regulations, we are delighted to inform that on recommendation of Nomination & Remuneration committee, the Board of Directors of the Company in its meeting held on Wednesday has appointed Ramanujam Reghunathan (Membership Number- FCA-024458) as the Chief Financial Officer of the Company with effect from May 25 2022. As per the provisions of Section 203 of the Companies Act 2013 read with relevant applicable rules Mr. Ramanujam Reghunathan shall be a whole time key managerial personnel of the company.
26-05-2022
Bigul

Annual report for Lotus Eye Hospital and Institute Ltd. for FY-2022
26-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Dividend Updates

 Final dividend of Rs0.50 per share recommended by the board subject to approval by the Shareholders in the Annual General Meeting
25-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Related Party Transactions Half Year Ended 31/03/2022

 Related Party Transactions Half year ended 31/03/2022
25-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Financial Results For The Period And Year Ended March 31 2022

 Financial Results for the period and year ended March 31 2022
25-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 25 ,2022

 Outcome of Board Meeting held on May 25 ,2022
25-05-2022
Next Page
Close

Let's Open Free Demat Account